Tiratricol

Emcitate 350 Microgramos Comprimidos Dispersables

350 µg comprimido dispersableSpainAuthorisedAuthorised 5 May 2026

Product informationAsk Osler about it

In other countries

The same active substances on other registers, the same brand first.

Authorised centrally in the EU

This national listing belongs to a medicine the European Commission authorised for the whole EU.

EmcitateEuropean UnionAuthorised

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

Tiratricol

Emcitate 350 Microgramos Comprimidos Dispersables

350 µg comprimido dispersableSpainAuthorisedAuthorised 5 May 2026

Product informationAsk Osler about it

In other countries

The same active substances on other registers, the same brand first.

Authorised centrally in the EU

This national listing belongs to a medicine the European Commission authorised for the whole EU.

EmcitateEuropean UnionAuthorised

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

Packs

Pack	Code	Status
EMCITATE 350 MICROGRAMOS COMPRIMIDOS DISPERSABLES, 60 comprimidos	770427

Documents

The official texts, at the regulator.

Sources and licences

Compiled by Prognia from the public register below; the register’s text is the official one.

Agencia Española de Medicamentos y Productos Sanitarios

Fuente de la información: Agencia Española de Medicamentos y Productos Sanitarios www.aemps.gob.es; CIMA medicamentos, acquired 11 October 2026 UTC; each source response/update date retained.

Licence: AEMPS explicit public open-data reuse for citizens and companies; source attribution and update date required · Added 12 Oct 2026

Report an error or request removalCorrections from the holder or the register are welcome.

Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.

At a glance

Active substance: Tiratricol
Strength: 350 µg
Dosage form: comprimido dispersable
Route: vía oral
Register: Spain (AEMPS)
Status: Authorised
Status in the register: Autorizado, no comercializado
Authorised: 5 May 2026
Registration: 1241897001
Marketing authorisation holder: Rare Thyroid Therapeutics International Ab
Procedure: EU centralised
Supply: Uso Hospitalario
EU number: EU/1/24/1897